Propofol suppresses lung cancer tumorigenesis by modulating the circ ‐ERBB2/miR‐7‐5p/FOXM1 axis
ConclusionsPropofol inhibited lung cancer progression via mediating circ ‐ERBB2/miR‐7‐5p/FOXM1 axis, which might provide an effective therapeutic target for lung cancer therapy.
Source: Thoracic Cancer - Category: Cancer & Oncology Authors: Jie Gao,
Chengzhi Ding,
Junhui Zhou,
Gang Wu,
Zongmao Han,
Jianchao Li,
Feilong Hei Tags: ORIGINAL ARTICLE Source Type: research
More News: Anesthesia | Anesthesiology | Cancer | Cancer & Oncology | Cancer Therapy | Cardiovascular & Thoracic Surgery | Diprivan | Lung Cancer | Propofol | Study